Severe, refractory type II essential mixed cryoglobulinemia treated with 2-chlorodeoxyadenosine and mycophenolate mofetil

Douglas E. Gladstone, Marc G. Golightly, Kenneth W. Zamkoff

Research output: Contribution to journalArticlepeer-review

Original languageEnglish (US)
Pages (from-to)635-636
Number of pages2
JournalRheumatology International
Issue number8
StatePublished - Oct 2005
Externally publishedYes


  • 2-Chlorodeoxyadenosine
  • Birmingham vasculitis activity score
  • Essential mixed cryoglobulinemia
  • Mycophenolate mofetil

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this